Targeting downstream effectors of epidermal growth factor receptor/HER2 in breast cancer with either farnesyltransferase inhibitors or mTOR antagonists (Q36607545)
scientific article published on September 2006
Language:
Current Data About Targeting downstream effectors of epidermal growth factor receptor/HER2 in breast cancer with either farnesyltransferase inhibitors or mTOR antagonists
(P31) (Q13442814)
(P248)
(P698) 17010069
(P813) Tuesday, August 15, 2017

(P304) 543-548
(P248)
(P698) 17010069
(P813) Tuesday, August 15, 2017

(P478) 16 Suppl 2
(P248)
(P698) 17010069
(P813) Tuesday, August 15, 2017

(P577) Friday, September 1, 2006
(P248)
(P698) 17010069
(P813) Tuesday, August 15, 2017

(P1433) (Q15749181)
(P248)
(P698) 17010069
(P813) Tuesday, August 15, 2017

(P1476) "Targeting downstream effectors of epidermal growth factor receptor/HER2 in breast cancer with either farnesyltransferase inhibitors or mTOR antagonists" (language: en)
(P248)
(P698) 17010069
(P813) Tuesday, August 15, 2017

(P2093) Johnston SR
(P1545) 1
(P248)
(P698) 17010069
(P813) Tuesday, August 15, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article published on September 2006

External Links
(P356) 10.1111/J.1525-1438.2006.00692.X
(P698) 17010069